相关实验视频
Updated: Jun 14, 2025

Technique for Intranasal Administration of α-Synuclein Aggregates
Published on: November 8, 2024
异型滴状形成由促炎性S100A9和与神经退行性疾病相关的α-Synuclein
Dominykas Veiveris1, Aurimas Kopustas1,2, Darius Sulskis1
1Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius LT-10257, Lithuania.
有助于炎症的S100A9蛋白与α-synuclein形成液体-液体相分离 (LLPS) 滴. 这种相互作用改变了α-synuclein聚合,为神经退行性疾病机制提供了洞察力.
科学领域:
- 生物化学 生化学
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 液-液相分离 (LLPS) 对于生物分子凝聚物形成至关重要.
- 神经退行性疾病的蛋白质,如α-synuclein和β-amyloid可以形成异型滴.
- 有助于炎症的S100A9会影响氨基原蛋白聚合.
研究的目的:
- 为了研究S100A9和α-synuclein之间的异型滴滴形成.
- 了解S100A9-alpha-synuclein相互作用如何影响蛋白质聚合机制.
主要方法:
- 使用S100A9和α-synuclein混合物探索异型凝结物形成.
- 分析由于S100A9相互作用而导致的α-synuclein聚合途径的变化.
主要成果:
- S100A9和α-synuclein混合物形成了同型和异型的凝聚物.
- S100A9和α-synuclein之间的交叉相互作用改变了α-synuclein的聚合机制.
结论:
- S100A9在LLPS和α-synuclein的聚合中发挥作用.
- 研究结果提供了S100A9对神经退行性疾病相关蛋白质行为的影响的见解.
更多相关视频
09:16Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
Published on: June 26, 2018
10:03Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
相关概念视频
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Neural Regulation
Parkinson's Disease: Overview